<?xml version="1.0" encoding="UTF-8"?>
<p>Among the proteins that are pivotal for CoV viral replication are the main proteases (Mpro) such as the chymotrypsin-like protease (3CLpro) and the papain-like proteases (PPL). These enzymes process viral polyproteins and control replicase complex activity (
 <xref rid="B10" ref-type="bibr">Anand et al., 2003</xref>), figuring as very attractive targets for drug development against CoVs. Several natural products and synthetic peptides have been reported to inhibit Mpro (
 <xref rid="B45" ref-type="bibr">Cinatl et al., 2005</xref>; 
 <xref rid="B229" ref-type="bibr">Vuong et al., 2020</xref>).
</p>
